Rockwell Medical (RMTI) Environmental, Social & Governance (ESG) Data

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Clean Climate Environment Environmental Environmental Protection Hazard Intensity Materials Nature Offset Package Packaging Pandemic Raw Materials Recycled Regenerative Waste Water Access African American Asian Benefits Black Collective Bargaining Community Customer Cyber Death Demographic Demographics Disability Diversity Employee Engagement Ethnic Ethnicity Gender Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Incident Injured Injury Latinx LGBTQ Opioid Pay for Performance Product Quality Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Supplier Supply Chain Talent Training Union Volunteer Workers Working Condition Activist Anti-corruption Assessment Assurance Audit Bonus Chronic Classified Clawback Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Enterprise Risk Management Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigant Litigation Long-term Majority Oversee Oversight Pledging Proxy Contest Purpose R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Special Meeting Strategy Targets Tax Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 9, 2022, Rockwell Medical, Inc. (the “Company”) held its 2022 Annual Meeting of the Stockholders (the “Annual Meeting”). The following matters were submitted to a vote of the stockholders at the Annual Meeting and the voting results were as follows:

Proposal One: To elect the Class I director to serve for a three-year term expiring at the 2025 annual meeting of stockholders and until his successor has been duly elected and qualified.

		For			Against			Abstain			Broker Non-Votes
Allen Nissenson, M.D.		24,041,638			2,393,357			528,617			35,799,968

Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers.

For			Against			Abstain			Broker Non-Votes
21,176,311			5,154,232			633,069			35,799,968

Proposal Three: To ratify the selection of Marcum LLP as the Company’s independent registered public accounting firm for 2022.

For				Against			Abstain
	59,196,022			2,231,488			1,336,070

Proposal Four: To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock with no change to the number of authorized shares of the Company’s common stock.

For				Against			Abstain
	51,696,755			10,648,535			418,290

Proposal Five: The proposal to approve and adopt amendments to the Company’s Certificate of Incorporation to (a) increase the number of authorized shares of the Company’s common stock from 170,000,000 shares to 340,000,000 shares and (b) effect a reverse stock split of the Company’s common stock with a 55 percent decrease to the number of authorized shares of the Company’s common stock was withdrawn because the Company’s stockholders approved and adopted Proposal Four as noted above.

Proposal Six: To approve an amendment and restatement of the Rockwell Medical, Inc. 2018 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 5,000,000 shares.

For			Against			Abstain		Broker Non-Votes
19,769,445			6,967,282			226,885			35,799,968